Business Insider -
16 Jun 2014 01:36

Medical device-maker Medtronic has agreed to acquire peer Covidien for $42.9 billion in cash and stock. The purchase values Covidien at $93.22 per Covidien share. Covidien closed at $72.02 on Friday. "We are excited to reach this agreement with Covidien, which further advances our mission to alleviate pain, restore health and extend life for patients around the world," said Medtronic CEO Omar Ishrak. "This acquisition will allow Medtronic to reach more patients, in more ways and in more places."...
Share this Article
Comment on this Article
Please to comment